This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IMedX Appoints Christopher Foley New Chief Executive Officer

MONROE, Conn., July 9, 2013 /PRNewswire/ -- iMedX, a leading provider of healthcare clinical documentation solutions, today announced the appointment of longtime industry veteran Christopher Foley to Chief Executive Officer and member of iMedX's board of directors. Former CEO Venkat Sharma will remain active in the company and its board, transitioning to a new role focused on forward-looking entrepreneurial ventures.

Chris brings 25 years of senior executive leadership experience to the position, including seven at publicly traded CBay Systems - now known as M*Modal - where he served as President and a member of its board of directors. His career includes senior roles at Lanier Worldwide, a global market leader in document management solutions. He was CEO and Founder of BSI, an international telecommunications technology and services consolidator in partnership with AT&T. Mr. Foley was also Vice President of publicly traded MedQuist, a multinational medical services BPO provider, and CEO and Founder of Priam Limited, a healthcare strategic advisory and investment banking firm.

"Chris will be instrumental in the company's continued efforts to increase market share and shareholder value," said Venkat Sharma, iMedX's Founder. "His proven track record and expertise will serve us well in our plan to rapidly expand into becoming a major force in the clinical documentation market."

"iMedX is a well-established and respected company. With our existing team of experienced leaders and dedicated resources, world-class technology solutions, and rapid implementation and integration methods, we will drive continuous value to our shareholders, our clients and our employees. Our passion for excellence and innovation is unmatched within the industry, and is our foundation as we implement a number of strategic growth and value-add initiatives," said Christopher Foley. "We will work to capitalize on what we view as a tremendous market opportunity. Our objective is to position iMedX as a market leader in integrated clinical documentation solutions by providing and enhancing the services that remain core and have the greatest impact on our clients."

About iMedX

iMedX is a leading outsource provider of healthcare software and services to hospitals and medical practices throughout the United States. iMedX's innovative Internet-based transcription delivery platform, TurboScribe®, is used by thousands of providers across the country. iMedX's TurboDox™ suite of services enable doctors to document rapidly and stay productive throughout EHR implementation. iMedX is headquartered in Monroe, CT. For more information, please visit


Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs